AICoin uses gains from crypto trading to acquire capital participation in Al startups. Sevamob provides artificial intelligence platforms enabled for healthcare
AICoin, a tokenized group that uses the gains from cryptocurrency operations to acquire capital participation in artificial intelligence (AI) startups, has just completed its first investment in Sevamob Ventures USA Inc.
AICoin, through Tessier-Ashpool PTE Ltd, is the main investor in this financing round of US $2,000,000 and it will gain a seat on Sevamob’s Board of Directors. Other participants in the round include USA-based Sorenson Impact Foundation, Impact Assets, and HNIs.
About Sevamob
Sevamob, an AI platform provider for organizational healthcare that is part of the Innovations in Healthcare program of Duke University, is one of the new companies using technologies like artificial intelligence and telemedicine at emerging asset-light clinics to provide superior primary healthcare to marginal populations at a discount of up to 50%.
Sevamob receives incomes from charging the delivery of software services and licenses. Sevamob currently executes 163 full-time and part-time units in India, South Africa and Georgia, USA, most of which are sustainable. More than 86 organizations are paying for their software and services.
Sevamob Model
Sevamob’s model B2B includes customers like schools, employers, ONG, corporate CSR, hospitals, clinics, pharmacies and the local governments. These customers, like Fullerton and Indian Oil, are associated with Sevamob for providing medical assistance to employees, communities and other beneficiaries. This assistance includes consultations, diagnoses at the point of care, and derivations for problems ranging from health in general, sight, dentistry and nutrition, to cardio-metabolic, infectious and ENT diseases.
Sevamob’s strength is the convenient onsite service, the coverage in urban and rural areas, with a lower cost due to its technology and live panels to monitor health results.
Gavin Smith, founder of AICoin and the CEO of the Panxora Group, stated:
“Sevamob is a good first investment as most of its units are already sustainable with a greater cost and scalability efficiency incorporated in its DNA. Its model is to establish a referential point of care for quality assistance with a medical team, and then use technology to increase efficiency and profitability of the services provided.”
Shelly Saxena, founder and CEO of Sevamob, has spent over 4 years refining the AI platform provider’s delivery model for a broad range of needs within the community since its creation.
Shelley has encountered major obstacles for providing direct medical services. This type of direction, together with innovation, is what increases a company’s probability of success.
The founder of AICoin, Marcie Terman, said:
“Investing in Sevamob marks the start of AICoin, acquiring capital participation in startups, focusing on the quality rather than on the quantity of investments.
When the founders and subscribers became involved with AICoin, it was not because they wanted to ‘become rich fast’. They did it be part of an experiment in which Artificial Intelligence Technology for making money is matched with “mass knowledge”, and its members have a voice to redirect the way money is invested.
It is not about a prejudiced risk capitalist that becomes part of a group that decides how to select investments, but about a group that benefits from a diversity of perspectives, knowledge and unique experiences.”
In this way, opportunities that venture capital (VCV) companies would normally overlook are identified.
By Willmen Blanco
